This grant supports collaborative and interdisciplinary research aimed at understanding cardiovascular disease development in individuals with type 1 diabetes. It focuses on mechanisms such as atherosclerosis, cardiomyopathy, and endothelial dysfunction, promoting innovative research to reduce morbidity and mortality. The funding continues the efforts of the CARE-T1D consortium and excludes clinical trials.
Eligible applicants include nonprofits, small businesses, public and private institutions of higher education, state and local governments, tribal governments and organizations, for-profit organizations other than small businesses, and public housing authorities. Foreign organizations are not eligib
